R

Active Director Director DIN 10810614
DIN 10810614 First appointment Oct 2024 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Oct 2024
Shareholding value Locked Premium profile

About Ranjana

Data last updated:

Ranjana has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Krown Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10810614
Primary Designation Director
First Appointment 16 Oct 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Krown Therapeutics Private Limited U21001PB2024PTC062707
Director16 Oct 20242024Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Krown Therapeutics Private Limited
Premium access

Shareholding and investment profile for Ranjana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjana

Ranjana has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Krown Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations.

Ranjana is associated with 1 company as Director.

Ranjana has expertise in General Business.

Ranjana has 1 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available